About Interferon regulatory factor 6
Interferon regulatory factor 6 (IRF6) is a protein
from Homo sapiens identified by UniProt accession
O14896, 467 residues long.
MolForge cross-references it against 0 known binders and
404 disease associations.
Target properties
| Protein name | Interferon regulatory factor 6 |
| UniProt accession | O14896 |
| Gene | IRF6 |
| Organism | Homo sapiens |
| Length | 467 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (404)
Diseases linked to this target (Open Targets).
- van der Woude syndrome 1 · score 0.79
- autosomal dominant popliteal pterygium syndrome · score 0.76
- van der Woude syndrome · score 0.76
- popliteal pterygium syndrome · score 0.73
- Cleft palate · score 0.59
- cleft palate · score 0.48
- cleft lip · score 0.47
- tooth agenesis · score 0.41
- genetic disorder · score 0.41
- Orofacial cleft · score 0.29
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O14896-F1 | alphafold | PREDICTED | 73.50 | — |
Amino-acid sequence (467 residues)
MALHPRRVRL KPWLVAQVDS GLYPGLIWLH RDSKRFQIPW KHATRHSPQQ EEENTIFKAW AVETGKYQEG VDDPDPAKWK AQLRCALNKS REFNLMYDGT KEVPMNPVKI YQVCDIPQPQ GSIINPGSTG SAPWDEKDND VDEEDEEDEL DQSQHHVPIQ DTFPFLNING SPMAPASVGN CSVGNCSPEA VWPKTEPLEM EVPQAPIQPF YSSPELWISS LPMTDLDIKF QYRGKEYGQT MTVSNPQGCR LFYGDLGPMP DQEELFGPVS LEQVKFPGPE HITNEKQKLF TSKLLDVMDR GLILEVSGHA IYAIRLCQCK VYWSGPCAPS LVAPNLIERQ KKVKLFCLET FLSDLIAHQK GQIEKQPPFE IYLCFGEEWP DGKPLERKLI LVQVIPVVAR MIYEMFSGDF TRSFDSGSVR LQISTPDIKD NIVAQLKQLY RILQTQESWQ PMQPTPSMQL PPALPPQ
Explore Interferon regulatory factor 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets